» Articles » PMID: 31655098

Advances in Eosinophilic Diseases in 2018

Overview
Date 2019 Oct 27
PMID 31655098
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Interest in eosinophil biology and eosinophilic diseases is increasing, as reflected in a doubling of the number of annual articles focused on this topic published in the Journal of Allergy and Clinical Immunology over the past decade. Although the majority of these publications relate to eosinophilic asthma, a growing proportion of them focus on breakthroughs in the diagnosis, treatment, and pathogenesis of other eosinophilic disorders, most notably eosinophilic esophagitis. This review highlights advances in our understanding of eosinophilia and eosinophilic disorders (excluding asthma) published in the Journal in 2018.

Citing Articles

Beyond CAR-T: The rise of CAR-NK cell therapy in asthma immunotherapy.

Mohammad Taheri M, Javan F, Poudineh M, Athari S J Transl Med. 2024; 22(1):736.

PMID: 39103889 PMC: 11302387. DOI: 10.1186/s12967-024-05534-8.


Clinico-pathological characteristics of eosinophilic esophagitis in Jordanian children.

Altamimi E, Ahmad B, Abu-Aqoulah A, Rawabdeh N Prz Gastroenterol. 2022; 17(3):207-212.

PMID: 36127947 PMC: 9475479. DOI: 10.5114/pg.2021.109975.


Treatment of allergic eosinophilic asthma through engineered IL-5-anchored chimeric antigen receptor T cells.

Chen S, Chen G, Xu F, Sun B, Chen X, Hu W Cell Discov. 2022; 8(1):80.

PMID: 35973984 PMC: 9381771. DOI: 10.1038/s41421-022-00433-y.


Leptin Elicits Eosinophil Migration and Activation: Key Role of Mast Cell-Derived PGD.

Amorim N, Souza-Almeida G, Luna-Gomes T, Bozza P, Canetti C, Diaz B Front Endocrinol (Lausanne). 2020; 11:572113.

PMID: 33117286 PMC: 7551309. DOI: 10.3389/fendo.2020.572113.